A Clinical Investigation of a Topical Moisturizer on Skin Barrier Function in Adults With Sensitive Skin
Part of paid clinical trials in New York, New York.
- Sponsor
- Good Molecules, LLC
- Study ID
- NCT07811531
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Sensitive Skin
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 55 Years
- Healthy Volunteers
- Not accepted
Interventions
- White petrolatum — OTHERDose per Application: 6 full pumps per application to the assigned forearm.
- Investigational moisturizer — OTHERDose per Application: 6 full pumps per application to the assigned forearm.
Study Details
The purpose of this research study is to evaluate whether a marketed moisturizing cream can improve skin barrier function (how well the outer layer of the skin keeps moisture in and protects the skin), skin hydration, skin sensitivity, inflammatory biomarkers (proteins in the skin that can provide information about inflammation), and the skin microbiome (the microorganisms that naturally live on the skin) in adults with sensitive skin, when compared with a commonly used moisturizing ointment (White Petrolatum) a widely used occlusive ointment (an ointment that forms a protective layer over the skin to help reduce moisture loss).
Key Dates
- First listed
- Sep 10, 2026
- Start date
- Sep 14, 2026
- Status verified
- Sep 2026
- Primary completion
- Dec 16, 2026
- Completion
- Jan 12, 2027
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Occlusive comparator controlWhite Petrolatum, USP
- Experimental: Investigational moisturizerMarketed Moisturizer
Primary Outcome Measure
Transepidermal Water Loss (TEWL) [ Time Frame: Baseline and Day 28 ]
Central Contacts
- Dashi, PhD+1 (646) 663-5260
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Sequential Skin | New York | New York | 10001 |